Kala Bio Inc (KALA)
6.82
+0.04
(+0.60%)
USD |
NASDAQ |
Nov 05, 11:44
Kala Bio Price to Book Value: 2.291 for Nov. 5, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 2.277 |
| November 01, 2024 | 2.348 |
| October 31, 2024 | 2.365 |
| October 30, 2024 | 2.301 |
| October 29, 2024 | 2.415 |
| October 28, 2024 | 2.415 |
| October 25, 2024 | 2.284 |
| October 24, 2024 | 2.200 |
| October 23, 2024 | 2.032 |
| October 22, 2024 | 1.858 |
| October 21, 2024 | 1.760 |
| October 18, 2024 | 1.747 |
| October 17, 2024 | 1.717 |
| October 16, 2024 | 1.767 |
| October 15, 2024 | 1.747 |
| October 14, 2024 | 1.737 |
| October 11, 2024 | 1.770 |
| October 10, 2024 | 1.767 |
| October 09, 2024 | 1.755 |
| October 08, 2024 | 1.784 |
| October 07, 2024 | 1.797 |
| October 04, 2024 | 1.814 |
| October 03, 2024 | 1.780 |
| October 02, 2024 | 1.810 |
| October 01, 2024 | 1.841 |
| Date | Value |
|---|---|
| September 30, 2024 | 1.915 |
| September 27, 2024 | 1.797 |
| September 26, 2024 | 1.764 |
| September 25, 2024 | 1.834 |
| September 24, 2024 | 1.854 |
| September 23, 2024 | 1.908 |
| September 20, 2024 | 1.945 |
| September 19, 2024 | 1.948 |
| September 18, 2024 | 1.948 |
| September 17, 2024 | 1.932 |
| September 16, 2024 | 1.935 |
| September 13, 2024 | 1.985 |
| September 12, 2024 | 1.999 |
| September 11, 2024 | 2.022 |
| September 10, 2024 | 1.985 |
| September 09, 2024 | 1.999 |
| September 06, 2024 | 2.015 |
| September 05, 2024 | 1.965 |
| September 04, 2024 | 2.022 |
| September 03, 2024 | 1.978 |
| August 30, 2024 | 1.965 |
| August 29, 2024 | 1.978 |
| August 28, 2024 | 1.982 |
| August 27, 2024 | 2.036 |
| August 26, 2024 | 2.059 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.017
Minimum
Mar 01 2023
13.79
Maximum
Mar 24 2020
3.286
Average
2.856
Median
May 02 2024
Price to Book Value Benchmarks
| CEL-SCI Corp | 5.871 |
| AIM ImmunoTech Inc | 2.567 |
| IGC Pharma Inc | 3.715 |
| NovaBay Pharmaceuticals Inc | -- |
| Protalix BioTherapeutics Inc | 3.319 |
Price to Book Value Related Metrics
| PS Ratio | 3.295 |
| Price | 6.82 |
| Earnings Yield | -204.5% |
| Market Cap | 31.42M |